Vimarsana
Biggest News Aggregation in the World

Page 18 - Expanded Access Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Expanded Access Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Expanded Access Program Today - Breaking & Trending Today

NRx Pharmaceuticals Reports Full Year 2022 Financial Results and Provides Business Update - Vimarsana News

NRx Pharmaceuticals Reports Full Year 2022 Financial Results and Provides Business Update

Over the past 12 months, the Company reinitiated its psychiatry development program post pandemic, transferred manufacturing of NRX-101 to the US, and...

NRx Pharmaceuticals Announces Positive Recommendation to Continue Enrollment in the Ongoing Trial of NRX-101 in Patients with Suicidal Treatment-Resistant Bipolar Depression - Vimarsana News

NRx Pharmaceuticals Announces Positive Recommendation to Continue Enrollment in the Ongoing Trial of NRX-101 in Patients with Suicidal Treatment-Resistant Bipolar Depression

/PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage CNS biopharmaceutical company, today reported...

Heidelberg Pharma concludes very successful financial year 2022 and reports on course of business - Vimarsana News

Heidelberg Pharma concludes very successful financial year 2022 and reports on course of business

EQS-News: Heidelberg Pharma AG / Key word: Annual Report Heidelberg Pharma concludes very successful financial year 2022 and reports on course of business 24.03.2023 / 07:11... | March 24, 2023

RedHill Biopharma Announces Plan to Implement ADS Ratio Change - Vimarsana News

RedHill Biopharma Announces Plan to Implement ADS Ratio Change

/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it plans to...

New Study Demonstrates Accurate Measurement of Left Ventricular Function Following Treatment with BioVentrix Revivent TC® Therapy - Vimarsana News

New Study Demonstrates Accurate Measurement of Left Ventricular Function Following Treatment with BioVentrix Revivent TC® Therapy

/PRNewswire/ -- BioVentrix®, Inc., a privately held medical device company developing less invasive therapies to directly treat the dilated left ventricle...